Financhill
Sell
44

FGEN Quote, Financials, Valuation and Earnings

Last price:
$8.48
Seasonality move :
21.45%
Day range:
$8.38 - $8.59
52-week range:
$4.85 - $21.94
Dividend yield:
0%
P/E ratio:
0.22x
P/S ratio:
29.24x
P/B ratio:
--
Volume:
7.2K
Avg. volume:
41.5K
1-year change:
-31.13%
Market cap:
$34.7M
Revenue:
$29.6M
EPS (TTM):
$39.34

Earnings Data

Next earnings date for FGEN
Mar 16
2026
Most recent earnings per share
$36.71
Beat by $40.72
(Nov 10/2025)
Consensus Estimate
-$4.01
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

FGEN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/16/2026 Q4 $1.7M -- -- -$4.17 --
11/10/2025 Q3 $1.6M $1.1M $36.71 -$4.01 $40.72
08/11/2025 Q2 $2.9M $1.3M -$1.88 $1.00 -$2.88
05/12/2025 Q1 $2M $2.7M $0.05 $0.50 -$0.45
03/17/2025 Q4 $24.9M $3.1M $4.46 -$5.00 $9.46
11/12/2024 Q3 $34.8M $123K -$4.25 -$9.50 $5.25
08/06/2024 Q2 $34.7M $998K -$3.89 -$6.00 $2.11
05/06/2024 Q1 $36.4M $25.4M -$8.32 -$7.75 -$0.57
02/26/2024 Q4 $38.8M $3.6M -$14.27 -$10.50 -$3.77
11/06/2023 Q3 -- $40.1M -$0.65 -- --
08/07/2023 Q2 -- $44.3M -$0.90 -- --
05/08/2023 Q1 -- $36.2M -$0.81 -- --
02/27/2023 Q4 -- $34.4M -$0.70 -- --
11/07/2022 Q3 -- $15.7M -$0.98 -- --
08/08/2022 Q2 -- $29.8M -$0.78 -- --
05/09/2022 Q1 -- $60.8M -$0.68 -- --
02/28/2022 Q4 -- $16.5M -$1.45 -- --
11/09/2021 Q3 -- $156M $0.54 -- --
08/09/2021 Q2 -- $24.4M -$1.45 -- --
05/10/2021 Q1 -- $38.4M -$0.78 -- --
03/01/2021 Q4 -- $65M -$16.08 -- --
11/05/2020 Q3 -- $44M $0.35 -- --
08/06/2020 Q2 -- $42.9M -$0.95 -- --
05/07/2020 Q1 -- $24.4M -$0.89 -- --
03/02/2020 Q4 -- $8M -$1.12 -- --
11/11/2019 Q3 -- $33.2M -$0.57 -- --
08/08/2019 Q2 -- $191.6M $1.26 -- --
05/09/2019 Q1 -- $23.9M -$0.53 -- --
02/27/2019 Q4 -- $108.1M $0.23 -- --
11/08/2018 Q3 -- $29M -$0.50 -- --
08/07/2018 Q2 -- $44M -$0.28 -- --
05/09/2018 Q1 -- $31.9M -$0.50 -- --
02/27/2018 Q4 -- $30.7M -$10.31 -- --
11/08/2017 Q3 -- $40.6M -$8.06 -- --
08/07/2017 Q2 -- $30.3M -$11.46 -- --
05/09/2017 Q1 -- $29.4M -$11.95 -- --
03/01/2017 Q4 -- $31.9M -$0.53 -- --
11/08/2016 Q3 -- $30.1M -$0.38 -- --
08/08/2016 Q2 -- $89.3M $0.35 -- --
05/09/2016 Q1 -- $28.3M -$0.45 -- --
02/29/2016 Q4 -- $24.4M -$0.83 -- --

FibroGen, Inc. Earnings Questions

  • How Much did FibroGen, Inc. Generate in Revenue Last Quarter?

    FibroGen, Inc. reported $1.1M worth of top line sales in its most recent quarter.

  • Did FibroGen, Inc. Beat Earnings Last Quarter?

    FibroGen, Inc. announced earnings per share of $36.71 which represents a beat of analyst forecast a -$4.01 per share.

  • Is FibroGen, Inc. Profitable?

    FibroGen, Inc. reported $942K that represents $0.23 per share over the last quarter.

  • What is the Analyst Consensus for FibroGen, Inc. EPS Next Year?

    FibroGen, Inc.'s earnings are forecast to decrease from -$11.89 per share to -$21.50 per share next year representing a decrease of -41.38%.

  • When is FibroGen, Inc.'s Earnings Date?

    FibroGen, Inc.'s next earnings date is March 16, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock